Group One Trading, L.P. Infla Rx N.V. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.74 $938 - $1,383	795 New	795 $1,000
Q3 2023 Nov 09, 2023	BUY	$2.66 - $4.33 $10,190 - $16,588	3,831 New	3,831 $11,000
Q1 2023 May 12, 2023	SELL	$1.66 - $3.1 $44,703 - $83,483	-26,930 Reduced 78.55%	7,353 $14,000
Q4 2022 Feb 09, 2023	BUY	$2.11 - $3.25 $38,477 - $59,267	18,236 Added 113.64%	34,283 $106,000
Q3 2022 Nov 09, 2022	BUY	$1.32 - $3.14 $21,182 - $50,387	16,047 New	16,047 $42,000
Q2 2021 Aug 10, 2021	SELL	$2.72 - $4.04 $272 - $404	-100 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$3.62 - $6.34 $1,086 - $1,902	-300 Reduced 75.0%	100 $0
Q4 2020 Feb 10, 2021	BUY	$3.82 - $5.32 $1,528 - $2,128	400 New	400 $2,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.